www.electronicdesign.com is using a security service for protection against online attacks. The service requires full cookie support in order to view this website.
Please enable cookies on your browser and try again.
www.electronicdesign.com is using a security service for pro
Lauren Cuthbertson needs no introduction.
Having worked with the Royal Ballet for 20 years and now being an award-winning Principal Dancer, she is a household name, starring in everything from Swan Lake and The Nutcracker to Alice in Wonderland and The Cellist.
This year is momento
As new security risks emerge and technologies improve, more sophisticated electronic security measures become necessary. This feature originally appeared in Automation 2022: Cybersecurity & Connectivity Volume 2.
When done correctly, enhanced electronic security can lead to enha
We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
It is a common saying that ‘oil and water don’t mix’, but this does not essentially apply in the case of lubrication oils. In lubric
Who was the guy? Jimmy Butler. The Miami Heat’s star didn’t have the prettiest shooting (13 of 29 from the field), but his 32 points, eight rebounds and four assists helped in a win over the Philadelphia 76ers that wasn’t as close as the final score said. Butler was forceful
New Jersey, United States – Comprehensive analyzes of the fastest-growing Battery Internal Resistance Meter Market provide insights that help stakeholders identify opportunities and challenges. The markets of 2022 could be another significant year for Battery Internal Resistance Met
Compartmentalising its latest turbines into easier-to-transport main nacelle and side units will deliver large-scale wind growth
Eisai Co., Ltd. (OTCPK:ESALF) Q4 2022 Earnings Conference Call May 13, 2022 3:30 AM ET
Ivan Cheung - Senior VP & President of Neurology Business Group
Teruyuki Masaka - VP & Chief Planning Officer
Takashi Owa - Senior VP, President & Chief Discovery Officer of On
Zealand Pharma Provides Update onRefocused Strategy Prioritizing Research and Development
Copenhagen, DK and Boston, MA, U.S. May 12, 2022 –Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) a biotechnology company focused on the discovery and development of innovative peptide